As every investor would know, not every swing hits the sweet spot. But really bad investments should be rare. So ...

IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth potential and a $1.5B repurchase plan.

In one advertisement, Fife flagged in 2023, a skin substitute representative whose company name has been redacted boasts of a ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Looking for random tidbits to bring out at your next dinner party? Here are 167 random fun facts suitable for anyone in your ...

Ruled by Mercury, the planet of the mind, full moons in Virgo can also stir up the tendency to overthink and worry. Because ...

Around four years ago, now 77-year-old John Gormly went for what was supposed to be a routine blood test. But the results were life-changing. The test suggested Gormly had colon cancer ...

According to a recent analysis by GlobalData, blood cancers overwhelmingly dominate the CAR-T therapy pipeline, with pharmaceutical leaders like Bristol Myers Squibb at the forefront of ...

New research highlights NHS approval gap compared to other cancers Research from the Blood Cancer Alliance reveals a significant disparity in access to new blood cancer treatments on the NHS. Between ...

THIS WEEKEND TO TALK ABOUT BLOOD CANCER. THE LATEST UPDATES AND RESOURCES FOR FINANCIAL HELP FOR PATIENTS AND THEIR FAMILIES. JOINING ME NOW FROM THE LEUKEMIA, LEUKEMIA AND LYMPHOMA SOCIETY IS ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to ...